Dallas, TX -- (SBWire) -- 06/25/2015 --The report "Equine Encephalitis - Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Equine Encephalitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Progressive Supranuclear Palsy and special features on late-stage and discontinued projects.
Complete report on Equine Encephalitis with 16 market data tables and 7 figures, spread across 31 pages is available at
http://www.rnrmarketresearch.com/equine-encephalitis-pipeline-review-h1-2015-market-report.html
Companies discussed in this Equine Encephalitis - Pipeline Review, H1 2015 report include EpiVax, Inc., Profectus BioSciences, Inc. and PsiOxus Therapeutics, Ltd.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Drug Profiles mentioned in this report are equine encephalitis vaccine, Monoclonal Antibody for Venezuelan Equine Encephalitis, VEEC-84, venezuelan equine encephalitis vaccine and Equine Encephalitis.
Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=392688
(This is a premium report priced at US$2000 for a single user License.)
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
List of Tables
Number of Products under Development for Equine Encephalitis, H1 2015 7
Number of Products under Development for Equine Encephalitis - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Number of Products under Investigation by Universities/Institutes, H1 2015 10
Comparative Analysis by Clinical Stage Development, H1 2015 11
Comparative Analysis by Early Stage Development, H1 2015 12
Products under Development by Companies, H1 2015 13
Products under Investigation by Universities/Institutes, H1 2015 14
Equine Encephalitis - Pipeline by EpiVax, Inc., H1 2015 15
Equine Encephalitis - Pipeline by Profectus BioSciences, Inc., H1 2015 16
Equine Encephalitis - Pipeline by PsiOxus Therapeutics, Ltd., H1 2015 17
Assessment by Monotherapy Products, H1 2015 18
Number of Products by Stage and Target, H1 2015 19
Number of Products by Stage and Route of Administration, H1 2015 20
Number of Products by Stage and Molecule Type, H1 2015 22
Equine Encephalitis - Dormant Projects, H1 2015 29
List of Figures
Number of Products under Development for Equine Encephalitis, H1 2015 7
Number of Products under Development for Equine Encephalitis - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Early Stage Products, H1 2015 12
Assessment by Monotherapy Products, H1 2015 18
Number of Products by Top 10 Molecule Types, H1 2015 21
Number of Products by Stage and Top 10 Molecule Types, H1 2015 22
Explore more reports on Diseases & treatment at
http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/diseases-treatment
About RnRMarketResearch.com
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Equine Encephalitis Pipeline Assessment Review H1 2015 Research Report Available at RnRMarketResearch.com
RnRMarketResearch.com adds “Equine Encephalitis - Pipeline Review, H1 2015” to its store. This report provides an overview of the Equine Encephalitis's therapeutic pipeline.